• About
  • News
  • Invest
  • – Merger
  • Spotlight Stock Market
  • Research
  • Patents
  • Antibiotic resistance
  • People
  • Contact
selectimmune-logo

Catharina Svanborg

Chairman of the Board/Founder

catharina.svanborg@med.lu.se
+ 46 70 42 65 49

Gabriela Godaly

Acting CEO

gabriela.godaly@selectimmune.com
+46 73 338 13 44

SelectImmune Pharma develops immunotherapies as alternatives to antibiotics. Our patented discoveries have shown protective efficacy and specificity in animal models of infection. Currently, five different drug candidates are being explored for development to proof-of-concept in clinical trials.
SelectImmune Pharma AB
Klinikgatan 32
SE-222 42 Lund
info@selectimmune.com
Org. no. 559104-6874